Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Phenylacetate in Pediatric Patients With Central Nervous System Tumors

NCT00003241 is registered in ClinicalTrials.gov with Texas Children's Cancer Center as lead sponsor.

NCT NCT00003241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Phenylacetate in Pediatric Patients With Central Nervous System Tumors
Lead sponsor
Texas Children's Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1998
Completion date
September 30, 2004
Enrollment
Not reported
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors